Review the literature that underpins the current use of poly ADP ribose polymerase inhibitors in the clinical treatment of cancers. Introduction History & Development of PARP inhibitors More background science & less clinical Concept of Synthetic Lethality Challenges & Current obstacles in the use of PARP inhibitors for the treatment of cancer Resistance Future Polytherapy